Suppr超能文献

T细胞介导的免疫抑制是P815肥大细胞瘤及其转移灶过继性免疫治疗的障碍。

T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases.

作者信息

Dye E S, North R J

出版信息

J Exp Med. 1981 Oct 1;154(4):1033-42. doi: 10.1084/jem.154.4.1033.

Abstract

Progressive growth of the P815 mastocytoma in semisyngeneic mice evokes the generation of a T cell-mediated mechanism of immunosuppression that inhibits the capacity of passively transferred, tumor-sensitized T cells from regressing this tumor in recipient mice. This conclusion is based on two findings: (a) that it is possible to demonstrate adoptive T cell-mediated regression of established tumors, but only if the tumors are growing in T cell-deficient recipients, and (b) that adoptive T cell-mediated regression of tumors in these recipients can be inhibited by the infusion of splenic T cells from T cell-intact, tumor-bearing donors. The results of additional experiments designed to measure the effect of decreasing the number of suppressor cells and the time that they are infused, relative immune cells, indicate that the function of suppressor cells in this model is to inhibit the replication of passively transferred immune T cells. The results obtained with the P815 mastocytoma are similar to those obtained previously with a chemically induced fibrosarcoma. They show, in addition, that passively transferred immune cells are capable of destroying already seeded metastases in T cell-deficient recipients.

摘要

P815肥大细胞瘤在半同基因小鼠体内的渐进性生长引发了一种T细胞介导的免疫抑制机制,该机制抑制了被动转移的、肿瘤致敏的T细胞在受体小鼠体内使这种肿瘤消退的能力。这一结论基于两项发现:(a)有可能证明过继性T细胞介导的已建立肿瘤的消退,但前提是肿瘤在T细胞缺陷的受体中生长;(b)在这些受体中,过继性T细胞介导的肿瘤消退可被来自T细胞完整、荷瘤供体的脾T细胞输注所抑制。旨在测量减少抑制细胞数量及其输注时间对相关免疫细胞影响的额外实验结果表明,该模型中抑制细胞的功能是抑制被动转移的免疫T细胞的复制。用P815肥大细胞瘤获得的结果与先前用化学诱导的纤维肉瘤获得的结果相似。此外,它们还表明,被动转移的免疫细胞能够在T细胞缺陷的受体中破坏已经接种的转移瘤。

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验